DE69925829D1 - Kurzes peptid zur behandlung neurodegenerativer erkrankungen - Google Patents
Kurzes peptid zur behandlung neurodegenerativer erkrankungenInfo
- Publication number
- DE69925829D1 DE69925829D1 DE69925829T DE69925829T DE69925829D1 DE 69925829 D1 DE69925829 D1 DE 69925829D1 DE 69925829 T DE69925829 T DE 69925829T DE 69925829 T DE69925829 T DE 69925829T DE 69925829 D1 DE69925829 D1 DE 69925829D1
- Authority
- DE
- Germany
- Prior art keywords
- gpl20
- treatment
- chemokines
- peptide
- brief
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8083698P | 1998-04-06 | 1998-04-06 | |
PCT/US1999/007514 WO1999051254A1 (en) | 1998-04-06 | 1999-04-06 | Short peptides for treatment of neurological degenerative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69925829D1 true DE69925829D1 (de) | 2005-07-21 |
Family
ID=22159933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69925829T Expired - Lifetime DE69925829D1 (de) | 1998-04-06 | 1999-04-06 | Kurzes peptid zur behandlung neurodegenerativer erkrankungen |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1075270B1 (de) |
JP (1) | JP2002510641A (de) |
AT (1) | ATE297942T1 (de) |
AU (1) | AU744044B2 (de) |
CA (1) | CA2327811A1 (de) |
DE (1) | DE69925829D1 (de) |
WO (1) | WO1999051254A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
MEP42108A (en) | 1998-10-23 | 2011-02-10 | Kiren Amgen Inc | Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
US7041506B2 (en) | 2001-11-19 | 2006-05-09 | Becton Dickinson And Company | Peptides promoting cell adherence, growth and secretion |
EP1773400A2 (de) | 2004-07-08 | 2007-04-18 | Amgen Inc. | Therapeutische peptide |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
US9283260B2 (en) | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
AT509611B1 (de) * | 2008-06-12 | 2012-04-15 | Affiris Forschungs-Und Entwicklungs Gmbh | Vakzin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5276016A (en) * | 1986-06-03 | 1994-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Small peptides which inhibit binding to T-4 receptors and act as immunogens |
US5567682A (en) * | 1988-12-16 | 1996-10-22 | Advanced Peptides And Biotechnology Sciences | Method of treating Alzheimer's disease |
-
1999
- 1999-04-06 EP EP99916409A patent/EP1075270B1/de not_active Expired - Lifetime
- 1999-04-06 JP JP2000542025A patent/JP2002510641A/ja not_active Withdrawn
- 1999-04-06 AT AT99916409T patent/ATE297942T1/de not_active IP Right Cessation
- 1999-04-06 DE DE69925829T patent/DE69925829D1/de not_active Expired - Lifetime
- 1999-04-06 WO PCT/US1999/007514 patent/WO1999051254A1/en active IP Right Grant
- 1999-04-06 CA CA002327811A patent/CA2327811A1/en not_active Abandoned
- 1999-04-06 AU AU34735/99A patent/AU744044B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU744044B2 (en) | 2002-02-14 |
CA2327811A1 (en) | 1999-10-14 |
EP1075270A1 (de) | 2001-02-14 |
EP1075270B1 (de) | 2005-06-15 |
JP2002510641A (ja) | 2002-04-09 |
WO1999051254A1 (en) | 1999-10-14 |
AU3473599A (en) | 1999-10-25 |
EP1075270A4 (de) | 2004-03-03 |
ATE297942T1 (de) | 2005-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121447T1 (el) | Συνθεσεις για αυξηση δραστηριοτητας τελομερασης | |
ATE242633T1 (de) | Dialkylfumarate zur behandlung von autoimmunerkrankungen | |
Kozlowski et al. | Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. | |
SE8902638L (sv) | Stabiliserade protein- eller peptidkonjugat | |
BR0009964A (pt) | Peptìdios artificiais com atividade desuperfìcie e sua utilização na preparação de surfactante artificial | |
DE69925829D1 (de) | Kurzes peptid zur behandlung neurodegenerativer erkrankungen | |
ATE337339T1 (de) | Therapeutische verwendung von smr1 protein und seinen aktiven derivaten | |
BR9808804A (pt) | Processos para tratar um indivìduo para melhorar o funcionamento do trato gastrointestinal superior incluindo o esÈfago e o estÈmago, para tratar um indivìduo para proliferar o tecido do trato gastrointestinal superior, para identificar peptìdeos utilizável para tratar condições inflamatórias, para identificar peptìdeos, utilizável para evitar ou melhorar as condições inflamatórias, utilizável para identificar peptìdeos capazes de proliferar tecido do trato gastrointestinal superior, para tratar profilaticamente um indivìduo, para melhorar o crescimento do tecido do trato gastrointestinal superior em um mamìfero, e para tratar um indivìduo para melhorar o funcionamento do trato gastrointestinal superior, kit, processos para promover o crescimento de tecido do trato gastrointestinal superior ou células, para tratar um paciente para restaurar o trato gastrointestinal superior, para determinar a atividade de um hormÈnio quando usado em combinação com glp-2, para tratar um indivìduo tendo úlceras peptìdicas | |
US5627035A (en) | Peptides that block human immunodeficiency virus and methods of use thereof | |
CN101679495B (zh) | 用于细胞学和免疫学调节的短的生物活性肽 | |
DE60031016D1 (de) | Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen | |
CN110114060A (zh) | 具有杀菌作用的制剂 | |
WO2000073427A3 (en) | Acetylcholinesterase-derived peptides and uses thereof | |
PT759772E (pt) | Tri- tetra- penta e polipeptidos e a sua utilizacao terapeutica como agente antidepressivo | |
Zammit et al. | Macrophage response during axonal regeneration in the axolotl central and peripheral nervous system | |
ATE373091T1 (de) | Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen | |
EP0415999B1 (de) | Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten | |
KR100488038B1 (ko) | 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도 | |
ES2134254T3 (es) | Expresion del factor osteogenico op-1 de celulas de spodoptera frugiperda infectadas con baculovirus recombinante. | |
AU1318797A (en) | Peptides and uses thereof for therapy of celiac diseases | |
Schlemm et al. | Medicinal yeast extracts | |
FR2745185B1 (fr) | Utilisation de l'il-7 dans le traitement des maladies auto-immunes, en particulier le diabete mellitus insulinodependant | |
EP1760090A1 (de) | Regulatorische/entfaltende Peptide von Ezrin | |
James | Stanford NAC study: glutathione level predicts survival | |
JP2020505324A5 (de) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |